Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-02-01
1996-07-02
Jordan, Kimberly
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514821, A61K 3144
Patent
active
055322514
ABSTRACT:
The use of 3-benzoyl-3,7-diazabicyclo[3.3.1]nonane compounds of the general formula I ##STR1## in which R.sup.1 is an alkyl group having 1-6 carbon atoms or a cycloalkylalkyl group having 4-7 carbon atoms,
REFERENCES:
patent: 4459301 (1984-07-01), Binnig et al.
patent: 4550112 (1985-10-01), Schoen et al.
patent: 4556662 (1985-12-01), Binnig et al.
patent: 4742172 (1988-05-01), Schoen et al.
patent: 4912113 (1990-03-01), Schoen et al.
patent: 4959373 (1990-07-01), Lubisch et al.
patent: 5164401 (1992-11-01), Burow et al.
CA 111:115218, Lubisch et al., 1989.
Brueckner Reinhard
Meil Joerg
Schoen Uwe
Thormaehlen Dirk
Jordan Kimberly
Kali-Chemie Pharma GmbH
LandOfFree
Method of treating cardiac arrhythmia with 3-benzoyl-3, 7-diazab does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating cardiac arrhythmia with 3-benzoyl-3, 7-diazab, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating cardiac arrhythmia with 3-benzoyl-3, 7-diazab will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1506664